Equities research analysts expect Cerner Co. (NASDAQ:CERN) to post earnings of $0.65 per share for the current fiscal quarter, Zacks reports. Ten analysts have provided estimates for Cerner’s earnings, with the highest EPS estimate coming in at $0.67 and the lowest estimate coming in at $0.63. Cerner reported earnings of $0.63 per share in the same quarter last year, which indicates a positive year over year growth rate of 3.2%. The firm is expected to announce its next earnings report on Thursday, October 24th.

On average, analysts expect that Cerner will report full-year earnings of $2.68 per share for the current fiscal year, with EPS estimates ranging from $2.64 to $2.70. For the next year, analysts forecast that the business will post earnings of $3.18 per share, with EPS estimates ranging from $3.04 to $3.33. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that follow Cerner.

Cerner (NASDAQ:CERN) last issued its earnings results on Wednesday, July 24th. The company reported $0.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.02. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.44 billion. Cerner had a net margin of 10.75% and a return on equity of 15.14%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.62 earnings per share.

CERN has been the topic of several research analyst reports. Zacks Investment Research lowered shares of Cerner from a “buy” rating to a “hold” rating and set a $77.00 price objective on the stock. in a research report on Monday, July 29th. Morgan Stanley increased their price objective on shares of Cerner from $49.00 to $62.00 and gave the company an “underweight” rating in a research report on Friday, August 23rd. Citigroup increased their price objective on shares of Cerner from $77.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. BidaskClub lowered shares of Cerner from a “sell” rating to a “strong sell” rating in a research report on Friday, September 6th. Finally, Bank of America raised their price target on shares of Cerner from $70.00 to $77.00 and gave the stock a “buy” rating in a research report on Tuesday, May 21st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $74.73.

Shares of CERN traded down $0.32 during trading hours on Monday, hitting $68.01. The company had a trading volume of 1,651,354 shares, compared to its average volume of 2,405,038. The firm has a market cap of $21.76 billion, a price-to-earnings ratio of 30.77, a PEG ratio of 1.88 and a beta of 0.92. The business has a fifty day moving average of $70.10 and a 200-day moving average of $67.02. Cerner has a 12 month low of $48.78 and a 12 month high of $76.47. The company has a quick ratio of 2.50, a current ratio of 2.52 and a debt-to-equity ratio of 0.22.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 9th. Shareholders of record on Wednesday, September 25th will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.06%. The ex-dividend date of this dividend is Tuesday, September 24th. Cerner’s dividend payout ratio is currently 32.58%.

In other news, EVP John Peterzalek sold 27,484 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $72.11, for a total value of $1,981,871.24. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Jeffrey A. Townsend sold 199,432 shares of Cerner stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $66.46, for a total transaction of $13,254,250.72. Following the sale, the vice president now owns 59,432 shares in the company, valued at $3,949,850.72. The disclosure for this sale can be found here. Over the last three months, insiders sold 288,377 shares of company stock worth $19,427,390. Insiders own 0.75% of the company’s stock.

A number of large investors have recently bought and sold shares of CERN. Acropolis Investment Management LLC increased its holdings in shares of Cerner by 2.0% during the second quarter. Acropolis Investment Management LLC now owns 7,494 shares of the company’s stock valued at $549,000 after acquiring an additional 148 shares in the last quarter. Advisor Partners LLC boosted its position in Cerner by 2.2% during the 2nd quarter. Advisor Partners LLC now owns 7,061 shares of the company’s stock worth $518,000 after buying an additional 154 shares during the period. Destination Wealth Management boosted its position in Cerner by 3.7% during the 2nd quarter. Destination Wealth Management now owns 5,208 shares of the company’s stock worth $382,000 after buying an additional 187 shares during the period. Coastal Investment Advisors Inc. boosted its holdings in Cerner by 16.3% during the 2nd quarter. Coastal Investment Advisors Inc. now owns 1,426 shares of the company’s stock worth $104,000 after acquiring an additional 200 shares during the last quarter. Finally, Berman Capital Advisors LLC boosted its holdings in shares of Cerner by 115.3% in the 2nd quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock worth $27,000 after buying an additional 204 shares during the last quarter. Institutional investors and hedge funds own 83.22% of the company’s stock.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: Why is the ex-dividend date different from the record date?

Get a free copy of the Zacks research report on Cerner (CERN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.